Correlation Between Reneo Pharmaceuticals and Apellis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Reneo Pharmaceuticals and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reneo Pharmaceuticals and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reneo Pharmaceuticals and Apellis Pharmaceuticals, you can compare the effects of market volatilities on Reneo Pharmaceuticals and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reneo Pharmaceuticals with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reneo Pharmaceuticals and Apellis Pharmaceuticals.
Diversification Opportunities for Reneo Pharmaceuticals and Apellis Pharmaceuticals
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Reneo and Apellis is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Reneo Pharmaceuticals and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and Reneo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reneo Pharmaceuticals are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of Reneo Pharmaceuticals i.e., Reneo Pharmaceuticals and Apellis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Reneo Pharmaceuticals and Apellis Pharmaceuticals
Given the investment horizon of 90 days Reneo Pharmaceuticals is expected to generate 0.93 times more return on investment than Apellis Pharmaceuticals. However, Reneo Pharmaceuticals is 1.07 times less risky than Apellis Pharmaceuticals. It trades about 0.53 of its potential returns per unit of risk. Apellis Pharmaceuticals is currently generating about 0.07 per unit of risk. If you would invest 1,620 in Reneo Pharmaceuticals on September 26, 2024 and sell it today you would earn a total of 200.00 from holding Reneo Pharmaceuticals or generate 12.35% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 12.7% |
Values | Daily Returns |
Reneo Pharmaceuticals vs. Apellis Pharmaceuticals
Performance |
Timeline |
Reneo Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Excellent
Apellis Pharmaceuticals |
Reneo Pharmaceuticals and Apellis Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Reneo Pharmaceuticals and Apellis Pharmaceuticals
The main advantage of trading using opposite Reneo Pharmaceuticals and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reneo Pharmaceuticals position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.Reneo Pharmaceuticals vs. Prime Medicine, Common | Reneo Pharmaceuticals vs. Ginkgo Bioworks Holdings | Reneo Pharmaceuticals vs. Ocean Biomedical | Reneo Pharmaceuticals vs. Royalty Pharma Plc |
Apellis Pharmaceuticals vs. Fate Therapeutics | Apellis Pharmaceuticals vs. Caribou Biosciences | Apellis Pharmaceuticals vs. Karyopharm Therapeutics | Apellis Pharmaceuticals vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |